ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Safety and efficacy of botulinum toxin type B for treatment of sialorrhea in Parkinson's disease: A prospective double-blind trial
Movement Disorders
◽
10.1002/mds.23929
◽
2011
◽
Vol 27
(2)
◽
pp. 219-226
◽
Cited By ~ 46
Author(s):
Robert Chinnapongse
◽
Kristen Gullo
◽
Paul Nemeth
◽
Yuxin Zhang
◽
Lynn Griggs
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Botulinum Toxin
◽
Botulinum Toxin Type
◽
Double Blind Trial
◽
Type B
◽
Double Blind
◽
Safety And Efficacy
◽
Blind Trial
◽
Botulinum Toxin Type B
Download Full-text
Related Documents
Cited By
References
Safety and efficacy of Myobloc® (botulinum toxin type B) for sialorrhea in Parkinson's disease (PD) patients
Toxicon
◽
10.1016/j.toxicon.2008.04.154
◽
2008
◽
Vol 51
◽
pp. 51
Author(s):
Pappert Eric
◽
Reinhard Sharon
◽
Salazar-Grueso Edgar
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Botulinum Toxin
◽
Botulinum Toxin Type
◽
Type B
◽
Safety And Efficacy
◽
Botulinum Toxin Type B
Download Full-text
Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) for the Treatment of Palmar Hyperhidrosis
Dermatologic Surgery
◽
10.1111/j.1524-4725.2005.31071
◽
2006
◽
Vol 31
(3)
◽
pp. 263-270
◽
Cited By ~ 10
Author(s):
Leslie Baumann
◽
Anele Slezinger
◽
Monica Halem
◽
Justin Vujevich
◽
Karin Mallin
◽
...
Keyword(s):
Botulinum Toxin
◽
Pilot Study
◽
Botulinum Toxin Type
◽
Palmar Hyperhidrosis
◽
Type B
◽
Double Blind
◽
Safety And Efficacy
◽
Botulinum Toxin Type B
Download Full-text
Double-Blind, Randomized, Placebo-Controlled Pilot Study of the Safety and Efficacy of Myobloc (Botulinum Toxin Type B) for the Treatment of Palmar Hyperhidrosis
Dermatologic Surgery
◽
10.1097/00042728-200503000-00002
◽
2005
◽
Vol 31
(3)
◽
pp. 263-270
◽
Cited By ~ 31
Author(s):
Leslie Baumann
◽
Anele Slezinger
◽
Monica Halem
◽
Justin Vujevich
◽
Karin Mallin
◽
...
Keyword(s):
Botulinum Toxin
◽
Pilot Study
◽
Botulinum Toxin Type
◽
Palmar Hyperhidrosis
◽
Type B
◽
Double Blind
◽
Safety And Efficacy
◽
Botulinum Toxin Type B
Download Full-text
Botulinum toxin type B: A double-blind, placebo-controlled, safety and efficacy study in cervical dystonia
Neurology
◽
10.1212/wnl.49.3.701
◽
1997
◽
Vol 49
(3)
◽
pp. 701-707
◽
Cited By ~ 177
Author(s):
M. F. Lew
◽
B. T. Adornato
◽
D. D. Duane
◽
D. D. Dykstra
◽
S. A. Factor
◽
...
Keyword(s):
Botulinum Toxin
◽
Cervical Dystonia
◽
Botulinum Toxin Type
◽
Efficacy Study
◽
Type B
◽
Double Blind
◽
Safety And Efficacy
◽
Double Blind Placebo
◽
Botulinum Toxin Type B
Download Full-text
Long-lasting benefits of botulinum toxin type B in Parkinson’s disease-related drooling
Journal of Neurology
◽
10.1007/s00415-009-0085-1
◽
2009
◽
Vol 256
(4)
◽
pp. 563-567
◽
Cited By ~ 51
Author(s):
Giovanni Lagalla
◽
Marzia Millevolte
◽
Marianna Capecci
◽
Leandro Provinciali
◽
Maria Gabriella Ceravolo
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Botulinum Toxin
◽
Botulinum Toxin Type
◽
Type B
◽
Botulinum Toxin Type B
Download Full-text
Faculty Opinions recommendation of Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial.
Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
◽
10.3410/f.717995409.793474520
◽
2013
◽
Author(s):
Cynthia Comella
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
The Parkinson-Control study: A 1-year randomized, double-blind trial comparing piribedil (150 mg/day) with bromocriptine (25 mg/day) in early combination with levodopa in Parkinson's disease
Movement Disorders
◽
10.1002/mds.20750
◽
2005
◽
Vol 21
(4)
◽
pp. 500-509
◽
Cited By ~ 29
Author(s):
Alexandre Castro-Caldas
◽
Paul Delwaide
◽
Wolfgang Jost
◽
Marcelo Merello
◽
Adrian Williams
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Double Blind Trial
◽
Double Blind
◽
Blind Trial
◽
Control Study
Download Full-text
Botulinum Toxin Type B for Hidradenitis Suppurativa: A Randomised, Double-Blind, Placebo-Controlled Pilot Study
American Journal of Clinical Dermatology
◽
10.1007/s40257-020-00537-9
◽
2020
◽
Vol 21
(5)
◽
pp. 741-748
Author(s):
Øystein Grimstad
◽
Bjørn Øivind Kvammen
◽
Carl Swartling
Keyword(s):
Botulinum Toxin
◽
Pilot Study
◽
Hidradenitis Suppurativa
◽
Botulinum Toxin Type
◽
Type B
◽
Double Blind
◽
Double Blind Placebo
◽
Botulinum Toxin Type B
Download Full-text
Extended-release carbidopa-levodopa (IPX066) compared with immediate-release carbidopa-levodopa in patients with Parkinson's disease and motor fluctuations: a phase 3 randomised, double-blind trial
The Lancet Neurology
◽
10.1016/s1474-4422(13)70025-5
◽
2013
◽
Vol 12
(4)
◽
pp. 346-356
◽
Cited By ~ 120
Author(s):
Robert A Hauser
◽
Ann Hsu
◽
Sherron Kell
◽
Alberto J Espay
◽
Kapil Sethi
◽
...
Keyword(s):
Parkinson’S Disease
◽
Parkinson's Disease
◽
Extended Release
◽
Immediate Release
◽
Motor Fluctuations
◽
Double Blind Trial
◽
Phase 3
◽
Double Blind
◽
Blind Trial
Download Full-text
Reduction in injection pain with botulinum toxin type B further diluted using saline with preservative: A double-blind, randomized controlled trial
Journal of the American Academy of Dermatology
◽
10.1067/mjd.2003.487
◽
2003
◽
Vol 48
(6)
◽
pp. 875-877
◽
Cited By ~ 25
Author(s):
S. Van Laborde
◽
Jeffrey S. Dover
◽
Megan Moore
◽
Brigitte Stewart
◽
Kenneth A. Arndt
◽
...
Keyword(s):
Randomized Controlled Trial
◽
Botulinum Toxin
◽
Controlled Trial
◽
Botulinum Toxin Type
◽
Injection Pain
◽
Type B
◽
Double Blind
◽
Randomized Controlled
◽
Botulinum Toxin Type B
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close